Jubilant Pharmova Limited (BOM:530019)
India · Delayed Price · Currency is INR 978.25
+16.25 (1.69%)
At close: Jul 27, 2026
Jubilant Pharmova Market Cap
Jubilant Pharmova has a market cap or net worth of 154.95 billion as of July 27, 2026. Its market cap has decreased by -16.90% in one year.
Market Cap
154.95B
Enterprise Value
178.45B
Revenue
82.80B
Ranking
n/a
PE Ratio
39.01
Stock Price
978.25
ChartMarket Cap Chart
Since May 30, 2000, Jubilant Pharmova's market cap has increased from 406.73M to 154.95B, an increase of 37,996.83%. That is a compound annual growth rate of 25.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 154.95B | -8.98% |
| Dec 31, 2025 | 170.24B | -2.67% |
| Dec 31, 2024 | 174.91B | 101.48% |
| Dec 29, 2023 | 86.81B | 45.28% |
| Dec 30, 2022 | 59.75B | -36.05% |
| Dec 31, 2021 | 93.44B | -30.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pharmaceuticals | 425.76B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Rubicon Research | 250.45B |
| Granules India | 206.58B |
| AstraZeneca Pharma India | 200.00B |
| Caplin Point Laboratories | 187.34B |
| CORONA Remedies | 129.23B |
| Procter & Gamble Health | 111.61B |